Andere talen Inspira Technologies Oxy B.H.N. Ltd.

Aandelen

IINN

IL0011715781

Beurs gesloten - Nasdaq Andere beurzen 21:59:57 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,21 ^USD	+0,45%		+17,55%	+108,49%

02/05	Inspira? Kondigt de productiestart van de Inspira aan? Art100	CI
17/04	Inspira Technologies OXY B.H.N. Ltd ondertekent een Term Sheet voor samenwerking met het Beilinson Ziekenhuis in Israël voor de evaluatie van haar gepatenteerde INSPIRA ART100 apparaat in orgaantransplantatieprocedures	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Inspira? Announces Start of Production of the Inspira? Art100	02/05
Inspira Technologies OXY B.H.N. Ltd Signs Collaboration Term Sheet with the Beilinson Hospital in Israel for the Evaluation of Its Proprietary INSPIRA ART100 device in Organ Transplant Procedures	17/04
Inspira, Beilinson Hospital Collaborate on Organ Transplant Device Evaluation	16/04
Inspira?? and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth Causes Bloodstream Infections	10/04
Inspira? Technologies Oxy B.H.N. Ltd. Announces Program to Pioneer the Applicable Use of the INSPIRA? ART100 Device for an Artificial Womb	03/04
Inspira Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager	02/04
Inspira Technologies Reports Full Year 2023 Financial Results	26/03
Inspira Technologies Oxy B.H.N. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	25/03
Inspira Technologies OXY B.H.N. Ltd. Announces AMAR Regulatory Submission of the INSPIRA? ART100, to Enter the Southeast Asia and South American Markets	18/03
Inspira Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator	12/03
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	08/03
INSPIRA TECHNOLOGIES OXY B H N : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K	04/03
Inspira Technologies Oxy B.H.N. Ltd. Plans to Report the Primary Results for A Core Blood Oxygenation Technology Within Days	04/03
Inspira Announces Breakthrough Update, Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements	28/02
Inspira to Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone	28/02
Inspira Technologies Oxy B.H.N. Ltd. Announces Approval from the U.S. Food & Drug Administration for its INSPIRA ART100 in the First Half of 2024	27/02
Inspira Technologies OXY B.H.N. Ltd. Introduces High-End Platform for Bio-Mimicking Blood parameters for Development and Testing of Core Technologies	22/02
Inspira Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System	15/02
Sector Update: Health Care Stocks Gain Late Afternoon	14/02
Sector Update: Health Care Stocks Rise in Afternoon Trading	14/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Inspira Technologies Oxy B.H.N. Ltd.

Aandelen

IINN

IL0011715781

Andere talen

Filters